IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

B Group, Inc.

Portfolio Profile

CIK: 0002043476 | DALLAS, TX

Investment Profile

Style

Value

Turnover

Low

Orientation

Concentrated trader
$176.2M
AUM
18
Positions
79.23%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Adma Biologics Inc(ADMA)3,262,542$27.3M12.82%
2Palisade BIO Inc(PALI)11,414,285$23.9M11.20%
3NRX Pharmaceuticals Inc(NRXP)4,091,767$16.7M7.86%
4Faeth Therapeutics Inc(SNSE)610,169$15.3M7.16%
5Taysha Gene Therapies Inc(TSHA)1,800,556$12.3M5.76%

Sector Allocation

Latest filing, equity positions only

Healthcare100% · $176.2M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare100%100%0%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

Cap SizePrev %Curr %Change
Mid Cap44.41%

AUM History

$163.6M | 18 pos.
$116.7M | 19 pos.
$129.9M | 17 pos.
$135.9M | 20 pos.
$135.4M | 16 pos.
$134.9M | 20 pos.
6
Praxis Precision Medicines I(PRAX)
33,237
$11.1M
5.22%
7Cellectis S A(CLLS)3,281,501$9.8M4.62%
8ZAI LAB LTD(ZLAB)450,646$8.6M4.02%
9Structure Therapeutics Inc(GPCR)140,000$7.5M3.53%
10Oruka Therapeutics Inc(ORKA)75,000$7.1M3.35%
34.47%
-9.94%
Micro Cap22.62%34.33%+11.71%
Small Cap32.97%31.21%-1.76%
$213.0M | 19 pos.
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

2
New
3
Closed
5
Increased
1
Decreased
11
Unchanged